Clinical Scorecard: Teen Liver Disease: Simple Math Beats BMI
At a Glance
| Category | Detail |
|---|---|
| Condition | Non-Alcoholic Fatty Liver Disease (NAFLD) |
| Key Mechanisms | Weight-adjusted waist index (WWI) correlates with NAFLD prevalence. |
| Target Population | U.S. adolescents aged 12 to 19 years, particularly males aged 16 and older. |
| Care Setting | Pediatric and adolescent healthcare settings. |
Key Highlights
- Increased WWI is associated with higher NAFLD prevalence (OR 3.37).
- Strong correlation when WWI values fall below 10.65 (OR 5.25).
- 80.13% of adolescents in the NAFLD group were overweight or obese.
- NAFLD is the most prevalent chronic liver condition in pediatric patients.
- WWI may provide superior predictive value for NAFLD risk compared to BMI.
Guideline-Based Recommendations
Diagnosis
- Liver ultrasound transient elastography used for NAFLD diagnosis.
- Hepatic steatosis defined as median Controlled Attenuation Parameter of 248 dB/m or higher.
Management
- Monitor for diabetes, prediabetes, and hypertension in NAFLD patients.
Monitoring & Follow-up
- Evaluate clinical markers including alanine aminotransferase and triglycerides.
Risks
- Higher rates of diabetes, prediabetes, and hypertension in NAFLD patients.
Patient & Prescribing Data
Adolescents aged 12 to 19 years in the U.S.
WWI offers a straightforward method for identifying hepatic steatosis.
Clinical Best Practices
- Utilize WWI for assessing visceral obesity in adolescents.
- Consider demographic factors such as age, race, and sex in NAFLD risk assessment.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
